ALS News Today Home | ALS News Today
5 days ago · A Texas Children’s Hospital investigator has received a $2.4 million grant for a study that seeks to understand whether mechanisms used by bacteria to hide from the immune system can be explored to ease inflammation in amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Steven Boeynaems, PhD, an investigator….
Amyotrophic Lateral Sclerosis (ALS) Symptoms – ALS News Today
Feb 6, 2023 · Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which worsening muscle weakness leads to movement problems and other symptoms such as trouble swallowing, speaking, and breathing. Patients also can experience digestive issues, mental health problems, and changes in behavior. Also known as Lou Gehrig’s disease, after the ...
Types of Amyotrophic Lateral Sclerosis (ALS) – ALS News Today
Mar 8, 2023 · Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that can be classified into different types based on factors like genetics, a patient’s family history, and the disorder’s early symptoms. Across all types, ALS is marked by the loss of motor neurons, the nerve cells that control voluntary muscle movements ...
Amyotrophic Lateral Sclerosis (ALS) Causes | ALS News Today
Feb 2, 2023 · Causes of ALS. The exact cause of amyotrophic lateral sclerosis (ALS) is largely unknown, but a number of factors including genetics, environmental exposures, and lifestyle habits have been linked to an increased risk of ALS. Also known as Lou Gehrig’s disease, named after the famous baseball player who was diagnosed with the disorder in 1939 ...
What is Amyotrophic Lateral Sclerosis (ALS)? | ALS News Today
Mar 20, 2023 · FAQs. Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that damages nerve cells and causes disability. The condition also is known as Lou Gehrig’s disease, after the famed New York Yankees baseball player who was diagnosed with the disorder in the late 1930s. ALS specifically damages motor neurons, the nerve cells ...
Phase 1 clinical trial of experimental ALS therapy AKV9 to soon...
Aug 28, 2023 · Akava Therapeutics will soon launch a Phase 1 clinical trial to test AKV9, its investigational therapy for amyotrophic lateral sclerosis (ALS), in healthy people. The trial follows the clearance of Akava’s investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA). It will be AKV9’s first-in-human study and is ...
Relyvrio for ALS – ALS News Today
Apr 11, 2024 · Relyvrio (sodium phenylbutyrate and taurursodiol) was an oral treatment approved in the U.S. and Canada to slow disease progression in adults with amyotrophic lateral sclerosis (ALS) that has now been discontinued. The therapy had shown in early clinical trials the ability to slow functional declines and to significantly extend patient survival ...
News Archives - ALS News Today
A Texas Children’s Hospital investigator has received a $2.4 million grant for a study that seeks to understand whether mechanisms used by bacteria to hide from the immune system can be explored to ease inflammation in amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Steven Boeynaems, PhD, an investigator….
The stages of amyotrophic lateral sclerosis (ALS) - ALS News Today
Jun 13, 2024 · Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder marked by progressively worsening stages of progression.People with ALS experience muscle weakness and neurological dysfunction, but initial symptoms are typically mild and affect only one part of the body. As the disease becomes more and more severe, these issues gradually spread to the entire body, affecting a range of ...
ALS Facts and Statistics – ALS News Today
The disease is most common among people 60 years or older, but nearly 10 percent of ALS patients are 45 or younger. Although ALS is 20 percent more likely to develop in men than in women, with advancing age, the gender difference disappears. Moreover, Caucasians and non-Hispanics are more likely to develop ALS compared with other ethnic groups.